- Home
- Publications
- Publication Search
- Publication Details
Title
Glucagon Control on Food Intake and Energy Balance
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 16, Pages 3905
Publisher
MDPI AG
Online
2019-08-12
DOI
10.3390/ijms20163905
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exciting advances in GPCR-based drugs discovery for treating metabolic disease and future perspectives
- (2019) Mar Quiñones et al. Expert Opinion on Drug Discovery
- The brown adipose tissue glucagon receptor is functional but not essential for control of energy homeostasis in mice
- (2019) Jacqueline L. Beaudry et al. Molecular Metabolism
- Glucagon-receptor Signaling Regulates Energy Metabolism Via Hepatic Farnesoid X Receptor and Fibroblast Growth Factor 21
- (2018) Teayoun Kim et al. DIABETES
- MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study
- (2018) Philip Ambery et al. LANCET
- A novel dual glucagon-like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo-controlled first-in-human and first-in-patient trials
- (2018) Joachim Tillner et al. DIABETES OBESITY & METABOLISM
- Anti-Obesity Therapy: from Rainbow Pills to Polyagonists
- (2018) T. D. Müller et al. PHARMACOLOGICAL REVIEWS
- Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists
- (2017) Andreas Evers et al. JOURNAL OF MEDICINAL CHEMISTRY
- The New Biology and Pharmacology of Glucagon
- (2017) T. D. Müller et al. PHYSIOLOGICAL REVIEWS
- Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice
- (2017) Sigrid Jall et al. Molecular Metabolism
- Unimolecular Polypharmacy for Treatment of Diabetes and Obesity
- (2016) Matthias H. Tschöp et al. Cell Metabolism
- Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates
- (2016) S. J. Henderson et al. DIABETES OBESITY & METABOLISM
- Glucagon increases energy expenditure independently of brown adipose tissue activation in humans
- (2015) V. Salem et al. DIABETES OBESITY & METABOLISM
- Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
- (2015) Darleen A. Sandoval et al. PHYSIOLOGICAL REVIEWS
- Hypothalamic CaMKKβ mediates glucagon anorectic effect and its diet-induced resistance
- (2015) Mar Quiñones et al. Molecular Metabolism
- Glucagon Is Essential for Adaptive Thermogenesis in Brown Adipose Tissue
- (2014) Keita Kinoshita et al. ENDOCRINOLOGY
- A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
- (2014) Brian Finan et al. NATURE MEDICINE
- A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties
- (2013) Vikas K. Bhat et al. BIOCHEMICAL PHARMACOLOGY
- Central GLP-2 Enhances Hepatic Insulin Sensitivity via Activating PI3K Signaling in POMC Neurons
- (2013) Xuemei Shi et al. Cell Metabolism
- GLP-1/Glucagon Coagonism Restores Leptin Responsiveness in Obese Mice Chronically Maintained on an Obesogenic Diet
- (2013) C. Clemmensen et al. DIABETES
- Fibroblast Growth Factor 21 Mediates Specific Glucagon Actions
- (2013) K. M. Habegger et al. DIABETES
- A DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed mice
- (2013) V. K. Bhat et al. DIABETOLOGIA
- A Novel Glucagon-like Peptide-1 (GLP-1)/Glucagon Hybrid Peptide with Triple-acting Agonist Activity at Glucose-dependent Insulinotropic Polypeptide, GLP-1, and Glucagon Receptors and Therapeutic Potential in High Fat-fed Mice
- (2013) Victor A. Gault et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity
- (2011) Victor A. Gault et al. CLINICAL SCIENCE
- The metabolic actions of glucagon revisited
- (2010) Kirk M. Habegger et al. Nature Reviews Endocrinology
- Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
- (2009) A. Pocai et al. DIABETES
- A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
- (2009) Jonathan W Day et al. Nature Chemical Biology
- The Glucagon Receptor Is Required for the Adaptive Metabolic Response to Fasting
- (2008) Christine Longuet et al. Cell Metabolism
- Physiology of the pancreatic α-cell and glucagon secretion: role in glucose homeostasis and diabetes
- (2008) Ivan Quesada et al. JOURNAL OF ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search